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Abstract: The world is currently witnessing an outbreak of a new coronavirus spreading quickly
across China and affecting at least 24 other countries. With almost 65,000 infected, a worldwide
death toll of at least 1370 (as of 14 February 2020), and with the potential to affect up to two-thirds
of the world population, COVID-19 is considered by the World Health Organization (WHO) to
be a global health emergency. The speed of spread and infectivity of COVID-19 (also known as
Wuhan-2019-nCoV) are dramatically exceeding those of the Middle East respiratory syndrome
coronavirus (MERS-CoV) and severe acute respiratory syndrome coronavirus (SARS-CoV). In fact,
since September 2012, the WHO has been notified of 2494 laboratory-confirmed cases of infection
with MERS-CoV, whereas the 2002–2003 epidemic of SARS affected 26 countries and resulted in more
than 8000 cases. Therefore, although SARS, MERS, and COVID-19 are all the result of coronaviral
infections, the causes of the coronaviruses differ dramatically in their transmissibility. It is likely that
these differences in infectivity of coronaviruses can be attributed to the differences in the rigidity
of their shells which can be evaluated using computational tools for predicting intrinsic disorder
predisposition of the corresponding viral proteins.
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Before the MERS-CoV outbreak in 2012, we built a model using artificial intelligence (AI) tools
for the identification of the levels of predicted intrinsic disorder (PID) in a query protein using its
amino acid sequence as the only input [1]. Next, this information was applied to rank various
coronaviruses based on the levels of disorder in their inner and outer shells (i.e., PID values evaluated
for their nucleocapsid (N) and membrane (M) proteins, respectively) and to find if these shell PID
values were indicative of how long the given virus was able to stay in the environment [1–3]. The
application of this model ranked coronaviruses into three groups (Categories A, B, and C), members of
which differ not only by the levels of their shell disorder, but also by their respiratory and fecal-oral
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transmission potential [1–3]. The model was consistent with the hypothesis that viruses remaining in
harsh environments require harder, i.e., less disordered, shells to survive [2,3]. Furthermore, higher
levels of inner shell disorder could be associated with greater infectivity, especially with regard to the
viruses with high respiratory transmission potential [3–5].
On the basis of these considerations, Category A coronaviruses are characterized by more
disordered inner (N) shell and higher levels of respiratory transmission combined with lower levels of
fecal-oral transmission. Category B coronaviruses are characterized by the N shell having intermediate
levels of disorder and intermediate levels of respiratory and fecal-oral transmission, whereas Category
C coronaviruses possess the most ordered N proteins and are characterized by higher levels of fecal-oral
transmission and lower levels of respiratory transmission [1–5]. Notably, some (not all) of the viruses
with lower outer shell rigidity (higher M PID) are in Category C with greater fecal-oral transmission
potential because these viruses do not have to be in the environment for a long time given that the
fecal-oral route is an efficient mode of transmission among some farm animals.
According to this PID-based classification, SARS-CoV (with PIDs of 9% and 50% for its M and N
proteins, respectively) falls into Category B, which includes the coronaviruses with the intermediate
levels of both respiratory and fecal-oral potential. However, MERS-CoV, whose M and N proteins are
characterized by the PID values of 10% and 44%, respectively, were placed into a group with a higher
fecal-oral and lower respiratory transmission potential, Category C [5]. Importantly, this classification
of coronaviruses which is based on the rigidity of their shells was generally supported by clinical
observations of their transmission modes.
The usefulness of our model is now becoming obvious, considering the current COVID-19/Wuhan
2019-nCoV outbreak [6]. Currently, the analysis suggests (details of this analysis will be published
elsewhere [7]) that COVID-19/Wuhan 2019-nCoV belongs to Category B, indicating that, similar to
SARS-CoV, COVID-19/Wuhan 2019-nCoV can be efficiently transmitted via the respiratory mode.
However, due to the fact that the outer shell of this virus is among the hardest in the coronavirus
family, the model suggests that COVID-19/Wuhan 2019-nCoV is likely to be more resilient in body
fluids and the environment than most of its cousins, including SARS-CoV and MERS-CoV.
Therefore, our model predicts that COVID-19/Wuhan 2019-nCoV can be efficiently spread by
respiratory means, as in the case of SARS-CoV, but it also has the potential to remain outside the body
longer than SARS-CoV, and, probably, MERS-CoV. The possibility of fecal-respiratory transmission of
COVID-19/Wuhan 2019-nCoV is especially of concern, as was the case for SARS-CoV in the Amoy
Garden, Hong Kong3. Furthermore, the intermediate levels of fecal-oral transmission potential of
COVID-19/Wuhan 2019-nCoV should also be kept in mind, as in the case of all other viruses in
Category B.
Although the ability to last longer outside the body provides better fitness of the virus that relies
more on the fecal-respiratory route of transmission, as seen in PEDV3,5, transmission of the more
rigid virus can occur via feces, but also in airborne form released from mucus, vomit, and other body
fluids. These properties can also explain the higher contagiousness levels of the COVID-19/Wuhan
2019-nCoV than with SARS-CoV [6]. In fact, the ability of COVID-19/Wuhan 2019-nCoV to remain
infectious outside the body for a longer period than SARS-CoV could imply that it requires fewer viral
particles for greater chances of infection. Furthermore, an infected body can shed more active viral
particles in greater concentrations as more particles are able to resist the digestive enzymes found in
most bodily fluids including saliva [2,3]. All these can explain not only high contagiousness of the
COVID-19/Wuhan 2019-nCoV but also the reported capability of this virus to be spread even before
the patient begins to show symptoms [6].
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